Mild cognitive impairment in Parkinson's disease
1Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University, Chicago, IL 60612, USA. jennifer_g_goldman@rush.edu
Minerva Medica
|December 24, 2011
Summary
Mild cognitive impairment in Parkinson's disease (PD-MCI) affects 20-50% of patients and presents varied cognitive deficits. Understanding PD-MCI is crucial for predicting dementia risk.
Area of Science:
- Neurology
- Neuroscience
- Cognitive Science
Background:
- Parkinson's disease (PD) is increasingly recognized for non-motor symptoms, including cognitive impairment.
- Mild cognitive impairment (MCI) is prevalent in non-demented PD patients, affecting 20-50%.
Purpose of the Study:
- To review the frequency, clinical features, and heterogeneity of mild cognitive impairment in Parkinson's disease (PD-MCI).
- To explore potential distinct PD-MCI profiles and their association with dementia risk.
Main Methods:
- Review of existing studies on PD-MCI frequency and clinical presentation.
- Analysis of cognitive domains affected in PD-MCI, including executive function, attention, and visuospatial skills.
- Exploration of biomarker studies (CSF, genetics, neuroimaging) in PD-MCI.
Main Results:
- PD-MCI exhibits heterogeneous cognitive phenotypes, with both amnestic and nonamnestic deficits observed.
- Patients with posterior cortical profiles in PD-MCI may have a higher risk of developing dementia.
- Biomarker research suggests the possibility of distinct PD-MCI subtypes.
Conclusions:
- Standardized diagnostic criteria and longitudinal studies are needed to fully understand PD-MCI.
- PD-MCI may represent a transitional state towards dementia in Parkinson's disease.
- Further research incorporating biomarkers is essential for characterizing PD-MCI profiles.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...